ACM
ANIP icon

AIGH Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

AIGH Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-272,801
Closed -$15.8M – 41
2023
Q3 		$15.8M Sell
272,801
-77,524
-22% -$4.47M 7.5% 1
2023
Q2 		$18.9M Buy
350,325
+2,219
+0.6% +$98.4K 7.7% 3
2023
Q1 		$13.8M Sell
348,106
-10,000
-3% -$422K 5.1% 7
2022
Q4 		$14.4M Buy
358,106
+43,700
+14% +$1.64M 4.75% 8
2022
Q3 		$10.1M Buy
314,406
+69,906
+29% +$2.39M 3.14% 10
2022
Q2 		$7.25M Buy
+244,500
New +$7.05M 1.91% 12

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

AIGH Capital Management's ANIP Position: Q4 2023 in Review

AIGH Capital Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2023, closing a stake of 272,801 shares — an estimated $15.8M sold.

AIGH Capital Management first reported a position in ANIP in Q2 2022 and held it in 6 quarters. The position peaked at $18.9M in Q2 2023. 182 funds tracked by Wall St. Rank hold ANIP as of Q4 2023.

  • AIGH Capital Management reported no remaining ANI Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • AIGH Capital Management sold 272,801 ANI Pharmaceuticals shares in Q4 2023, an estimated $15.8M.
  • AIGH Capital Management first reported a position in ANI Pharmaceuticals in Q2 2022 and held it in 6 quarters.
  • AIGH Capital Management's ANI Pharmaceuticals position peaked at $18.9M in Q2 2023.
  • 182 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2023.

Based on AIGH Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.